BioSciences Group of Fujitsu Computer Systems
License agreement with Ensemble Discovery signed for molecular modeling software
Published in Elder Law Weekly, November 16th, 2005
The license will also provide Ensemble with the BioSciences Group's ActiveSite module for designing effective small molecule inhibitors of protein targets.
The Fujitsu BioMedCAChe suite provides powerful tools to speed the drug discovery process by enabling scientists to predict and select quality leads. Analysis capabilities ranging from molecular mechanics to quantum mechanics and ab initio approaches are enabled on small...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2005-11-16)
More Articles from Elder Law Weekly
- M.D. Anderson Cancer Center
M. intracellulare infects women increasingly beyond menopause - Pacer Health Corporation
Acute care hospital operator reopens Louisiana Psychiatric Hospital - Samaritan Pharmaceuticals, Inc.
Alzheimer disease rat model offers insights into biomarker identification - Spedali Civil Brescia
Acromegaly predicts fracture risk in post-menopausal women - Affymax, Inc.
Hematide is potent erythropoiesis-stimulating agent for anemia due to cancer, kidney disease - Albert Einstein College of Medicine, Hyde Park
Meprin-alpha appears to play a role in chronic diabetic nephropathy - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
